146 related articles for article (PubMed ID: 38881050)
1. Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid.
Ahmadpoor P; Beck M; Michel M; Pambrun E; Stoebner P; Moranne O
J Clin Apher; 2024 Jun; 39(3):e22133. PubMed ID: 38881050
[TBL] [Abstract][Full Text] [Related]
2. Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid.
Yamada H; Yaguchi H; Takamori K; Ogawa H
Ther Apher; 1997 May; 1(2):178-82. PubMed ID: 10225767
[TBL] [Abstract][Full Text] [Related]
3. Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report.
Kitabata Y; Sakurane M; Orita H; Kamimura M; Siizaki K; Narukawa N; Kaketaka A; Abe T; Kobata H; Akizawa T
Ther Apher; 2001 Dec; 5(6):484-90. PubMed ID: 11800086
[TBL] [Abstract][Full Text] [Related]
4. Selective plasma exchange can reduce auto-antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogen.
Nasu K; Hanafusa N; Nangaku M
J Clin Apher; 2017 Dec; 32(6):589-591. PubMed ID: 27709645
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
6. A case of bullous pemphigoid successfully treated by plasmapheresis: assessment of the change in titers of circulating antibodies by immunoblotting and enzyme-linked immunosorbent assay.
Lee JB; Fumimori T; Kurose K; Mori O; Hashimoto T
J Dermatol; 2003 Apr; 30(4):326-31. PubMed ID: 12707470
[TBL] [Abstract][Full Text] [Related]
7. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM
Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment by double-filtration plasmapheresis of a patient with bullous pemphigoid: effects in vivo on transcripts of several genes for chemokines and cytokines in peripheral blood mononuclear cells.
Hatano Y; Katagiri K; Arakawa S; Umeki T; Takayasu S; Fujiwara S
Br J Dermatol; 2003 Mar; 148(3):573-9. PubMed ID: 12653753
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic use of plasmapheresis in a patient with bullous pemphigoid].
Bandemir W; Krëger E
Vestn Dermatol Venerol; 1989; (2):10-3. PubMed ID: 2658406
[TBL] [Abstract][Full Text] [Related]
10. [EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB].
Neumark M; Tal Y; Zlotogorski A; Molho-Pessach V
Harefuah; 2020 Jan; 159(1):29-30. PubMed ID: 31930804
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report.
Vico-Alonso C; Calleja-Algarra A; Aragón-Miguel R; Sánchez-Velázquez A; Velasco-Tamariz V; Ortiz-Romero PL; Monsálvez-Honrubia V
Dermatol Ther; 2019 Mar; 32(2):e12829. PubMed ID: 30659716
[TBL] [Abstract][Full Text] [Related]
12. Plasmapheresis as a steroid saving procedure in bullous pemphigoid.
Egan CA; Meadows KP; Zone JJ
Int J Dermatol; 2000 Mar; 39(3):230-5. PubMed ID: 10759969
[TBL] [Abstract][Full Text] [Related]
13. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
Alexandre M; Bohelay G; Gille T; Le Roux-Villet C; Soued I; Morin F; Caux F; Grootenboer-Mignot S; Prost-Squarcioni C
Front Immunol; 2022; 13():874108. PubMed ID: 35514989
[TBL] [Abstract][Full Text] [Related]
14. Bullous Pemphigoid Successfully Treated With a Combination Therapy of Plasmapheresis Followed by Intravenous High Dose Immunoglobulin.
Hattori Y; Takahashi T; Seishima M
Ther Apher Dial; 2017 Aug; 21(4):421-423. PubMed ID: 28378368
[No Abstract] [Full Text] [Related]
15. Development of bullous pemphigoid during the haemodialysis of a young man: case report and literature survey.
Osipowicz K; Kalinska-Bienias A; Kowalewski C; Wozniak K
Int Wound J; 2017 Feb; 14(1):288-292. PubMed ID: 27748034
[TBL] [Abstract][Full Text] [Related]
16. IgE blockade in autoimmunity: Omalizumab induced remission of bullous pemphigoid.
James T; Salman S; Stevenson B; Bundell C; Kelly G; Nolan D; John M
Clin Immunol; 2019 Jan; 198():54-56. PubMed ID: 30557620
[TBL] [Abstract][Full Text] [Related]
17. Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid.
Zhou T; Peng B; Geng S
Front Immunol; 2021; 12():718073. PubMed ID: 34504496
[TBL] [Abstract][Full Text] [Related]
18. Immunoadsorption for the treatment of bullous pemphigoid.
Ino N; Kamata N; Matsuura C; Shinkai H; Odaka M
Ther Apher; 1997 Nov; 1(4):372-6. PubMed ID: 10225735
[TBL] [Abstract][Full Text] [Related]
19. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
